ANTX:NASDAQ, AN2 Therapeutics, Inc.

ANTX stock overview

AN2 Therapeutics, Inc. (ANTX:NASDAQ) closed at $3.54 on October 14, 2026, down 1.67% on the day. The stock trades 50.8% below its 52-week high of $7.19 and 254.0% above its 52-week low of $1.00. Over the past year, it gained 190.3%. AN2 Therapeutics, Inc. is part of the Health Care sector.

Key figures

Price
$3.54
Day change
-1.67%
Volume
427,066
Average volume
239,853
Market cap
133M+
52-week range
$1.00 – $7.19
50-day average
$5.45
200-day average
$3.90

Performance

5D 1M 3M 6M 1Y
-18.18% -34.07% -22.91% -0.28% +190.32%

Price action over the past year

In 252 trading sessions since October 14, 2025, ANTX closed higher on 111 days (44%). Its best day was March 9, 2026 (+84.21%) and its worst was October 13, 2026 (-16.28%). The stock moved 10% or more in a single session 12 times. It opened at least 5% above the previous day's high 1 time.

Recent signals

ANTX news

About AN2 Therapeutics, Inc.

AN2 Therapeutics Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The initial product candidate is epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial, or NTM, lung disease.

Find more stocks like ANTX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.